Myriad Genetics 1 article

Myriad Genetics is a molecular-diagnostics company spanning hereditary-cancer testing, companion diagnostics, pharmacogenomics and reproductive genetics. Its scientific profile includes germline variant analysis, hereditary-risk panels, carrier and prenatal screening, and disease-specific genomic assays used in oncology and other clinical settings. The entity is company-level: branded tests such as MyRisk, BRACAnalysis CDx, GeneSight, Foresight, Prequel, MyChoice or Prolaris are related products rather than alternate names for Myriad Genetics.

Breaking Biotech News

October 9, 2026, 12:13 PM · 5 mins read

FDA Greenlights for Pharma Heavyweights as Caribou and Foghorn Cut Deep

Roche, Novartis, Pfizer, and Eli Lilly landed key FDA approvals this week, while Caribou Biosciences and Foghorn Therapeutics moved to lay off staff and halt programs amid a tough funding squeeze.